Search research articles
Contact Us
Filters
Showing results (71-80 of 132) with videos related to
Page
of 14
Sort By:
British Journal of Haematology
|
September 22, 2009
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
Ali Taher, Maria D Cappellini, Elliott Vichinsky, et al.
Pediatric Radiology
|
November 2, 2004
Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
Anne Jones, Suzanne Granger, Don Brambilla, et al.
British Journal of Haematology
|
July 7, 2007
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator
Paul Harmatz, Robert W Grady, Paul Dragsten, et al.
JAMA Network Open
|
July 18, 2020
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial
Donald I Abrams, Paul Couey, Niharika Dixit, et al.
Pediatric Blood & Cancer
|
March 16, 2017
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST)
Elliott Vichinsky, Amal El-Beshlawy, Azzam Al Zoebie, et al.
American Journal of Hematology
|
September 3, 2005
Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia
Elliott Vichinsky, Ellen Butensky, Ellen Fung, et al.
Journal of Pediatric Hematology/Oncology
|
April 21, 2023
COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia
Susan T Paulukonis, Angela Snyder, Matthew P Smeltzer, et al.
American Journal of Hematology
|
August 7, 2013
Pain over time and its effects on life in thalassemia
Olivia Oliveros, Felicia Trachtenberg, Dru Haines, et al.
British Journal of Haematology
|
October 3, 2006
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease
Patrick B Walter, Ellen B Fung, David W Killilea, et al.
American Journal of Hematology
|
April 11, 2012
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
Abdullah Kutlar, Kenneth I Ataga, Lillian McMahon, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 132) with videos related to
Sort By:
Page
of 14
British Journal of Haematology
|
September 22, 2009
Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
Ali Taher, Maria D Cappellini, Elliott Vichinsky, et al.
Pediatric Radiology
|
November 2, 2004
Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?
Anne Jones, Suzanne Granger, Don Brambilla, et al.
British Journal of Haematology
|
July 7, 2007
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator
Paul Harmatz, Robert W Grady, Paul Dragsten, et al.
JAMA Network Open
|
July 18, 2020
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial
Donald I Abrams, Paul Couey, Niharika Dixit, et al.
Pediatric Blood & Cancer
|
March 16, 2017
Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST)
Elliott Vichinsky, Amal El-Beshlawy, Azzam Al Zoebie, et al.
American Journal of Hematology
|
September 3, 2005
Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia
Elliott Vichinsky, Ellen Butensky, Ellen Fung, et al.
Journal of Pediatric Hematology/Oncology
|
April 21, 2023
COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia
Susan T Paulukonis, Angela Snyder, Matthew P Smeltzer, et al.
American Journal of Hematology
|
August 7, 2013
Pain over time and its effects on life in thalassemia
Olivia Oliveros, Felicia Trachtenberg, Dru Haines, et al.
British Journal of Haematology
|
October 3, 2006
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease
Patrick B Walter, Ellen B Fung, David W Killilea, et al.
American Journal of Hematology
|
April 11, 2012
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
Abdullah Kutlar, Kenneth I Ataga, Lillian McMahon, et al.
Page
of 14